Sustained Antitumor Immunity Based on Persistent Luminescence Nanoparticles for Cancer Immunotherapy
- 27 September 2021
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 31 (52) , 2106884
Abstract
Immunotherapy holds great promise for cancer treatment. The key to improving the therapeutic effect is to drive the patient's own immune system to produce a strong, effective, and enduring tumor‐specific immune response. Engineered nanoplatforms show promising potential in strengthening antitumor immune responses. However, current nanotherapeutic platforms based on exogenous responses stimulate the immune system only in a transitory and limited manner, which translates into insufficient immune activation and a low therapeutic efficacy. A novel targeted nano‐immunostimulant (ZGS‐Si‐Pc@HA) is fabricated by coupling persistent luminescence nanoparticles with a photosensitizer and hyaluronic acid for sustained immune stimulation upon irradiation with biological window (659 nm) light. ZGS‐Si‐Pc@HA persistently drives reactive oxygen species production to induce immunogenic cell death, causing a durable tumor‐specific immune response. Upon intratumoral injection, ZGS‐Si‐Pc@HA effectively alleviates immune tolerance and promotes T lymphocyte tumor infiltration. Further, ZGS‐Si‐Pc@HA enhances the therapeutic effect of checkpoint blockade immunotherapy, effectively inhibiting bilateral tumor growth and triggering an immunological memory effect. Nano‐immunostimulants not only provide a new way to boost cancer immunotherapy, but also offer a reliable strategy for fighting cancer metastasis and recurrence clinically.Keywords
Funding Information
- National Natural Science Foundation of China (61705228, 21507129)
- Natural Science Foundation of Fujian Province (2019J05159)
This publication has 52 references indexed in Scilit:
- Enhanced Afterglow Performance of Persistent Luminescence Implants for Efficient Repeatable Photodynamic TherapyACS Nano, 2017
- Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal CancerACS Nano, 2017
- Conjugation of a photosensitizer to near infrared light renewable persistent luminescence nanoparticles for photodynamic therapyChemical Communications, 2016
- Direct Aqueous-Phase Synthesis of Sub-10 nm “Luminous Pearls” with Enhanced in Vivo Renewable Near-Infrared Persistent LuminescenceJournal of the American Chemical Society, 2015
- Neoantigens in cancer immunotherapyScience, 2015
- Immunoengineering: How Nanotechnology Can Enhance Cancer ImmunotherapyCell, 2015
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- Sunlight-activated long-persistent luminescence in the near-infrared from Cr3+-doped zinc gallogermanatesNature Materials, 2011
- Cancer Immunotherapy by Dendritic CellsImmunity, 2008
- The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph NodesCell, 2000